Status:

UNKNOWN

Prevalence of Bronchiectasis in COPD Patients

Lead Sponsor:

Assiut University

Conditions:

Bronchiectasis

Chronic Obstruct Airways Disease

Eligibility:

All Genders

18-80 years

Brief Summary

The identification of bronchiectasis in COPD has been defined as a different clinical COPD phenotype with greater symptomatic severity, more frequent chronic bronchial infection and exacerbations, and...

Detailed Description

The relationship between bronchiectasis and COPD has generated several questions. Is there any real increased prevalence of bronchiectasis in patients with COPD? Does the presence of bronchiectasis ha...

Eligibility Criteria

Inclusion

  • COPD patients based on GOLD 2019 criteria, stable or in exacerbation

Exclusion

  • acute pneumonia within 2 months
  • malignancy
  • congenital bronchiectasis ( immobile cilia syndrome, Kartagnar syndrome).
  • Pregnancy

Key Trial Info

Start Date :

September 30 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 30 2020

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04101448

Start Date

September 30 2019

End Date

September 30 2020

Last Update

September 24 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AssiutU

Asyut, Egypt, 71111